Anti-Leukocyte Adhesion For The Mitigation Of Potential Adverse Events Caused By CD3-Specific Binding Domains
Abstract The present invention relates in essence to a compound which decreases or inhibits the binding of mammalian T-cells to mammalian endothelial cells for use in a method of prophylaxis and/or amelioration and/or treatment of clinical adverse events caused by therapy which comprises re-directin...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
13.08.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!